Therapeutic Potential of Cyclodextrins Targeting Dengue Virus and SARS-CoV-2 Infection and Pathogenesis
Pedro Henrique Carneiro, Erika Vanessa Jiménez-Posada, Francielle Tramontini Gomes de Sousa, Scott B. Biering, Trishna S. Patel, Samhita Bhat, Sarah A. Stanley, John E. Pak, Peter Laing, Tamás Sohajda, Eva Harris, P. Robert Beatty
This study evaluates cyclodextrins' ability to reduce endothelial dysfunction and antiviral activity against DENV and SARS-CoV-2 in vitro and in vivo.
bioRxiv · Aug 3, 2025 · PreprintMicrobiology